What The Central Dogma Of Biology States That
It is a framework for understanding how genetic information moves through a cell. DNA makes RNA, and RNA makes protein. That is the basic sequence everyone learns in high school biology. It sounds simple because it is meant to be that way. But the details matter when you are actually working with molecular data, and most people gloss over them. I spent years doing RNA sequencing work, and the first time I ran into a problem with the central dogma wasn't in a textbook. It was a dataset where the transcriptome didn't match the genome at all. We had reads mapping to regions that weren't annotated. At first I thought the alignment parameters were wrong. They weren't. The genome had retrotransposon insertions that weren't in the reference, and the RNA was being transcribed from those. The dogma held up, but the reference material was incomplete. I fixed it by pulling in a separate repeat-masked genome and re-aligning. Took me about four hours instead of two days of debugging the pipeline.
The Central Dogma Of Biology States That
Francis Crick proposed it in 1958. He said information flows from nucleic acid to nucleic acid, or from nucleic acid to protein. He explicitly excluded the idea that information could flow from protein back to nucleic acid. That part still holds. Proteins don't rewrite your DNA sequence in response to their own activity. What has changed since then is the list of exceptions, and there are several of them. The main flow is transcription followed by translation. DNA is copied into messenger RNA by RNA polymerase. The mRNA then gets read by ribosomes, which link amino acids together into a polypeptide chain. That chain folds into a functional protein. This is the standard pathway in eukaryotes and prokaryotes alike. But there are deviations worth knowing about. Reverse transcriptase flips the script by making DNA from an RNA template. This happens in retroviruses like HIV, and it also happens inside your own genome through LINE-1 elements. Human cells carry active retrotransposons that copy themselves via an RNA intermediate and insert back into DNA. It isn't common, but it is real and it complicates things if you are tracking variant calls from RNA-seq data. If you see a DNA variant that looks like it came from RNA but shows up in the genome later, reverse transcription is a likely culprit.
RNA-dependent RNA polymerases exist too. Some viruses replicate their genomes this way. SARS-CoV-2 uses an RdRp for replication. Normal human cells don't have this enzyme, which is why RNA viruses are a whole different category to deal with in diagnostics. If you are building a PCR assay and your primers amplify something that shouldn't be there, check whether your sample could contain an RNA virus with a polymerase that copies RNA directly. Prions are another edge case. They are misfolded proteins that cause other proteins to misfold. No nucleic acid is involved in the transmission. Crick excluded this from his original framework, and rightly so, because it doesn't involve genetic information flow in the traditional sense. But it does challenge the idea that proteins are always the end product. Sometimes they are the vector. Here is something beginners routinely miss. The central dogma describes the direction of information flow, not the direction of physical movement. Proteins can move into the nucleus and regulate transcription. RNAs can move out of the nucleus and get translated. Signals can travel from the cytoplasm back to the genome and change chromatin state. None of that violates the dogma. What would violate it is if a protein sequence determined the nucleotide sequence of a gene. That doesn't happen. Ever.
Get the Full Details

Another thing people get wrong is thinking the dogma is a rigid pipeline. It isn't. Alternative splicing means one gene can produce multiple mRNA isoforms. RNA editing can change nucleotides after transcription. Both of these mean the relationship between gene and protein is many-to-many, not one-to-one. If you are annotating a genome and assuming one transcript per gene, you are going to undercount isoforms significantly. In humans, the average gene produces multiple splice variants. The ENCODE project estimated that over 90 percent of multi-exon genes undergo alternative splicing. When I was troubleshooting a differential expression project, I found that a gene we thought was downregulated in a condition was actually just producing a different splice variant. The total read count was stable, but the isoform shifted. A standard gene-level analysis missed it entirely. I had to switch to transcript-level quantification using something like Salmon or Kallisto, and the story changed completely. That saved us from publishing a false finding. There are also cases where the dogma breaks down in terms of what we consider functional output. Non-coding RNAs like microRNAs, long non-coding RNAs, and circular RNAs are transcribed from DNA but never translated into protein. They function as RNA. This doesn't contradict the dogma because the information still flows DNA to RNA. It just means the end product isn't always a protein. Crick himself acknowledged that the dogma was about information transfer, not about every RNA needing to become a protein.
If you are working in a lab and trying to validate a gene knockout, keep in mind that the central dogma assumes a linear path from gene to product. But compensatory mechanisms exist. If you knock out a gene, related genes can be upregulated. Protein stability can change. Post-translational modifications can compensate for reduced expression. I saw this with a knockdown of a metabolic enzyme where the cells survived by upregulating an alternative pathway. The dogma told us what to expect. Reality gave us something more complicated. The practical takeaway is that the central dogma is a useful starting point, not a complete description of cellular complexity. It works for standard molecular biology. It breaks down when you look closely at viral systems, retrotransposons, alternative splicing, RNA editing, and non-coding RNAs. Understanding where it applies and where it doesn't is what separates someone who recites the concept from someone who actually uses it. If you need a reference, Crick's original 1958 paper "On Protein Synthesis" is available through the Biological Reviews. His 1970 paper "Central Dogma of Molecular Biology" in Nature is the more commonly cited one. Both are short and worth reading directly rather than relying on textbook summaries.